Barrett's Esophagus, fundoplication, and cancer.
Watson
David I
DI
Mayne
George C
GC
Hussey
Damian J
DJ
D000230:Adenocarcinoma / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D001471:Barrett Esophagus / Q000453:epidemiology / Q000209:etiology / Q000601:surgery*; D001647:Bile Acids and Salts / Q000633:toxicity; D014408:Biomarkers, Tumor / Q000032:analysis; D018450:Disease Progression; D004938:Esophageal Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D018662:Fundoplication / Q000379:methods*; D005764:Gastroesophageal Reflux / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery*; D006801:Humans; D015994:Incidence; D018570:Risk Assessment; D017211:Treatment Failure
D000897:Anti-Ulcer Agents; D001647:Bile Acids and Salts; D014408:Biomarkers, Tumor